600645.SH
Vcanbio Cell & Gene Engineering Corp., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 17.61
+3.89%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.41x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.15x
- Net debt / EBITDA
- -4.47x
Liquidity & coverage
- Current ratio
- 1.88x
- Quick ratio
- 1.72x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 1.2B
Cash & dividend
- FCF / debt
- 4.70x
- Cash flow / debt
- 5.59x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -84.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026